These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7654055)
1. Urinary excretion of deoxypyridinoline in patients with breast cancer. Nguyen-Pamart M; Bonneterre J; Hecquet B Anticancer Res; 1995; 15(4):1601-3. PubMed ID: 7654055 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of urine deoxypyridinoline for detecting bone metastases in breast cancer patients. Hou MF; Lin SB; Yuan SS; Tsai LY; Tsai SM; Hsieh JS; Huang TJ Ann Clin Lab Sci; 2003; 33(1):55-61. PubMed ID: 12661898 [TBL] [Abstract][Full Text] [Related]
3. Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases. Walls J; Assiri A; Howell A; Rogers E; Ratcliffe WA; Eastell R; Bundred NJ Br J Cancer; 1999 Jun; 80(8):1265-70. PubMed ID: 10376982 [TBL] [Abstract][Full Text] [Related]
4. The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessment. Lüftner D; Günther S; Flath B; Müller C; Echteroff K; Mergenthaler HG; Wernecke KD; Possinger K Anticancer Res; 1999; 19(4A):2537-44. PubMed ID: 10470191 [TBL] [Abstract][Full Text] [Related]
5. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784 [TBL] [Abstract][Full Text] [Related]
6. Markers of bone resorption--measurement in serum, plasma or urine? Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175 [TBL] [Abstract][Full Text] [Related]
7. [Pyridinoline and deoxypyridinoline excretion in urine of healthy children--dependence on age]. Marowska J; Lukaszkiewicz J; Kobylińska M; Matusik H; Tałajko A; Lebiedowski M; Olszaniecka M; Madej M; Lorenc RS Pol Tyg Lek; 1993 Nov; 48 Suppl 3():39-42. PubMed ID: 8309836 [TBL] [Abstract][Full Text] [Related]
8. Serum bone specific alkaline phosphatase and urinary deoxypyridinoline in postmenopausal osteoporosis. Nawawi HM; Yazid TN; Ismail NM; Mohamad AR; Nirwana SI; Khalid BA Malays J Pathol; 2001 Dec; 23(2):79-88. PubMed ID: 12166596 [TBL] [Abstract][Full Text] [Related]
9. The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. Generali D; Berruti A; Tampellini M; Dovio A; Tedoldi S; Bonardi S; Tucci M; Allevi G; Aguggini S; Milani M; Bottini A; Dogliotti L; Angeli A Bone; 2007 Jan; 40(1):182-8. PubMed ID: 16935041 [TBL] [Abstract][Full Text] [Related]
10. Biochemical markers for assessment of bone metastases in patients with breast cancer. Hou MF; Tsai LY; Tsai SM; Huang CJ; Huang YS; Hsieh JS; Chan HM; Wang JY; Chuang CH; Chen FM; Huang TJ Kaohsiung J Med Sci; 1999 Aug; 15(8):452-60. PubMed ID: 10518361 [TBL] [Abstract][Full Text] [Related]
11. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Verit FF; Geyikli I; Yazgan P; Celik A Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321 [TBL] [Abstract][Full Text] [Related]
12. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis. Shaarawy M; Zaki S; Sheiba M; El-Minawi AM Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333 [TBL] [Abstract][Full Text] [Related]
13. Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer. Marttunen MB; Hietanen P; Titinen A; Roth HJ; Viinikka L; Ylikorkala O Calcif Tissue Int; 1999 Nov; 65(5):365-8. PubMed ID: 10541761 [TBL] [Abstract][Full Text] [Related]
14. The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women. Oh KW; Rhee EJ; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Choi MG; Yoo HJ; Park SW Clin Endocrinol (Oxf); 2004 Aug; 61(2):244-9. PubMed ID: 15272921 [TBL] [Abstract][Full Text] [Related]
15. Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments. Cloos PA; Christgau S; Lyubimova N; Body JJ; Qvist P; Christiansen C Breast Cancer Res; 2003; 5(4):R103-9. PubMed ID: 12818000 [TBL] [Abstract][Full Text] [Related]
16. [Monitoring markers of bone turnover in multiple myeloma]. Spicka I; Spacek P; Hulejová H; Procházka B; Cieslar P; Chrz M; Válková V; Klener P Vnitr Lek; 1999 Aug; 45(8):463-7. PubMed ID: 11045145 [TBL] [Abstract][Full Text] [Related]
17. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases. Voorzanger-Rousselot N; Journe F; Doriath V; Body JJ; Garnero P Calcif Tissue Int; 2009 May; 84(5):348-54. PubMed ID: 19252761 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of pyridinium crosslinks and CA 15-3 as markers in metastatic bone breast carcinoma. Massidda B; Ionta MT; Foddi MR; Mascia L; Bruder F; Aloi MB; Meleddu C; Giannoni MN Anticancer Res; 1996; 16(4B):2221-3. PubMed ID: 8694547 [TBL] [Abstract][Full Text] [Related]
19. Investigation of bone disease using isomerized and racemized fragments of type I collagen. Cloos PA; Fledelius C; Christgau S; Christiansen C; Engsig M; Delmas P; Body JJ; Garnero P Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813 [TBL] [Abstract][Full Text] [Related]
20. The renal clearance of free and conjugated pyridinium cross-links of collagen. Colwell A; Eastell R J Bone Miner Res; 1996 Dec; 11(12):1976-80. PubMed ID: 8970901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]